Rationally Designed LBP for the Treatment of Neurological Diseases
Time: 3:00 pm
day: Conference Day One Track B PM 1
Details:
- Outlining IrisRx – a platform for mechanistic based LBP drug development
- Rational selection of BL-001 strains in drugresistant epilepsy and ALS
- Sharing results of a pilot study with BL-001 in healthy volunteers
